CFOROTCServices-Medical LaboratoriesFiscal year ends December 31
CapForce Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$4.03+0.53 (+15.14%)
Close on Oct 19, 2026
- Market cap
- $50.33M
- P/E (TTM)
- 0.7
- Dividend yield
- –
CapForce Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Listing sponsorship services [Member] | $30.20M | $5.00M | – | – | – | – | – | – | – | 100.0% | +504.0% |
| Product [Member] | – | $169.37K | $2.40M | $1.89M | $2.66M | $2.70M | $2.17M | $2.40M | $2.77M | – | – |
| Laboratory Services [Member] | – | – | – | – | – | – | $5.44K | $34.67K | $41.96K | – | – |
| Collaboration revenue [Member] | – | – | $864.55K | $540.80K | $836.15K | $1.34M | $1.33M | $516.02K | $397.18K | – | – |
| Service [Member] | – | $26.78K | $153.72K | $172.63K | $813.21K | $167.74K | $5.44K | – | – | – | – |
| Laboratory services [Member] | – | $26.78K | – | – | – | – | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| International [Member] | $30.20M | $5.00M | $2.74M | $2.09M | $3.10M | $2.30M | $176.00K | – | – | 100.0% | +504.0% |
| Domestic [Member] | – | $196.15K | $678.09K | $520.61K | $1.20M | $1.92M | $3.32M | – | – | – | – |
From the segment and revenue-disaggregation notes of CapForce's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.